首页 | 本学科首页   官方微博 | 高级检索  
检索        

解毒化瘀法联合前列腺素E1治疗慢性肾脏疾病2~4期合并急性肾损伤的临床研究
引用本文:龚学忠,汤晓春,王骞,王跃荣.解毒化瘀法联合前列腺素E1治疗慢性肾脏疾病2~4期合并急性肾损伤的临床研究[J].临床肾脏病杂志,2014(11):666-669.
作者姓名:龚学忠  汤晓春  王骞  王跃荣
作者单位:1. 上海中医药大学附属市中医医院肾内科, 上海,200071
2. 上海中医药大学附属市中医医院 检验科, 上海,200071
基金项目:国家自然科学基金青年项目,国家自然科学基金面上项目
摘    要:目的:观察具有解毒化瘀功效的经验方剂川黄方联合前列腺素 E1治疗脾肾气虚、毒瘀互结型慢性肾脏疾病(chronic kidney disease,CKD)2~4期合并急性肾损伤(acute kidney inj ury, AKI)的临床疗效。方法选择CKD 2~4期合并AKI患者60例分为川黄方联合前列腺素E1组(治疗组)29例,前列腺素 E1组(对照组)31例。2组患者均接受纠正水、电解质、酸碱平衡紊乱,控制血压等常规治疗。在常规治疗基础上2组均静脉给予前列腺素 E120μg/d;治疗组同时服用川黄方中药汤剂,每日1剂;疗程均为2周。观察2组治疗前后的血肌酐(SCr)、血尿素氮(BUN)、血尿酸(uric acid,UA)、血清胱抑素C(cystatin,Cys C)、24 h尿蛋白定量,并统计中医证候疗效。结果①与治疗前相比,2组治疗均能有效降低 SCr、BUN、UA,差异均有统计学意义(P0.05),但均能改善患者中医证候,其中治疗组优于对照组(P〈0.01)。结论川黄方联合前列腺素E1能有效减轻CKD 2~4期合并AKI患者肾损伤、保护肾功能,并改善中医证候,优于单用前列腺素E1治疗。

关 键 词:解毒化瘀法  慢性肾脏病  急性肾损伤  前列腺素  E1

Clinical study of detoxification and removing blood stasis method combined with prostaglandin E1 in trea- ting phase 2-4 chronic kidney disease associated with acute kidney injury
GONG Xue-zhong,TANG Xiao-chun,WANG Qian,WANG Yue-rong.Clinical study of detoxification and removing blood stasis method combined with prostaglandin E1 in trea- ting phase 2-4 chronic kidney disease associated with acute kidney injury[J].Journal Of Clinical Nephrology,2014(11):666-669.
Authors:GONG Xue-zhong  TANG Xiao-chun  WANG Qian  WANG Yue-rong
Institution:GONG Xue-zhong,TANG Xiao-chun,WANG Qian,WANG Yue-rong(Department of Nephrology , Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai TCM University, Shanghai 200071, China)
Abstract:Objective To observe the clinical efficacy of Chuanhuang decoction,which has de-toxification and removing blood stasis function,combined with prostaglandin E1 in treating phase 2-4 chronic kidney disease (CKD)associated with acute kidney injury (AKI).Methods Sixty patients with AKI on phase 2-4 CKD admitted on Shanghai Municipal Hospital of Traditional Chinese Medicine were randomly divided into 2 groups,including treatment group (29 cases)and control group (3 1 ca-ses).All patients were given the same diet care and basic treatment.Treatment group was treated with Chuanhuang Fang decoction combined with prostaglandin E1 (20μg/day by intravenous adminis-tration),and control group with 20μg/day prostaglandin E1 by intravenous administration.The pa-tients were observed for two weeks.Serum creatinine (SCr),blood urea nitrogen (BUN),uric acid (UA),serum cystatin C (Cys C),and 24-h urine protein were determined and compared before and after treatment.Furthermore,total efficiency based on TCM symptom scores was calculated and ana-lyzed.Results After two-week treatment,SCr,BUN,UA and Cys C were significantly reduced in both two groups (P0.05).Treatment group achieved 96.6% of the total efficiency based on TCM symptom scores,higher than prostaglandin E1 group (77.4%)(P〈0.01).Conclusions Treatment group can relieve TCM symptoms and protect renal function in AKI on phase 2-4 CKD more effectively than in control group.Chuanhuang decoction and detoxification and remo-ving blood stasis method might be a potentially useful method for CKD associated with AKI.
Keywords:Detoxification and removing blood stasis method  Chronic kidney disease  Acute kidney inj ury  prostaglandin E1
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号